Reminder: Invitation to Roche investor conference call on the strategic collaboration with Foundation Medicine in the field of molecular information in oncology Montag, 12. Januar 2015 - 10:18

We kindly invite investors and analysts to participate in a conference call to discuss the announcement that Roche (SIX: RO, ROG; OTCQX: RHHBY) and Foundation Medicine, Inc. (NASDAQ: FMI) have entered into a broad strategic collaboration in which Roche will acquire a majority interest in Foundation Medicine.

Conference call will take place today (Monday, 12 January) at 1:30pm CET/12:30pm GMT/7:30am EST/4:30am PST and will start with presentations by senior management followed by a Q&A session (live access to the speakers).

Presenters:

Severin Schwan, CEO Roche Group

Alan Hippe, Chief Financial and IT Officer

Daniel O'Day, COO Pharmaceuticals

Please dial in to the conference 10-15 min prior to the scheduled start , using the following numbers:

+41 (0) 58 310 5000 (Europe and ROW)

+44 (0) 203 059 5862 (UK)

+1 (1) 631 570 5613 (USA)

Alternatively a live audio webcast can be accessed via http://ir.roche.com.

To expedite the registration process, you may pre-register for the event by clicking here.

Link to the presentation: http://www.roche.com/irp150112.pdf

With best regards,

Roche Investor Relations

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

Tamer Farhan Ph.D.
Phone: +41 61 68-82552
e-mail: tamer.farhan@roche.com

Dr. Stefan Foser
Phone: +41 61 68-71300
e-mail: stefan.foser@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

Investor Relations North America

Nina Goworek
Phone: +1 650 467 8737
e-mail: goworek.nina@gene.com

Ekaterine Kortkhonjia Ph.D.
Phone: +1 650 467 5873
e-mail: kortkhonjia.ekaterine@gene.com